Abstract
Since the term »microalbuminuria« (MA) was coined in 1982 [1] elevated albumin excretion rate has been regarded as the best indicator to signal early diabetic nephropathy [2–5]. Two main aspects of renal function at this stage of diabetic nephropathy, are the relation to glomerular structure and the impact of blood glucose control. Improved blood glucose control has been shown to reduce the risk of developing overt nephropathy in patients with MA [6,7] and retard the progression of AER [8], but the concomitant ultrastructural changes were not investigated.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Viberti GC, Mackintosh D, Bilous RW, Pickup JC, Keen H. Proteinuria in diabetes mellitus: Role of spontaneous and experimental variation of glycemia. Kidney Int 1982; 21: 714–720.
Parving H-H, Oxenbøll B, Svendsen PAA, Christiansen JS, Andersen AR. Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion. Acta Endocrinol (Copenh) 1982; 100: 500–505.
Viberti GC, Hill RD, Jarrett RI, Argyropoulos A, Mahmud U, Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1982; i: 1430–1432.
Mogensen CE, Christensen CK. Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 1984; 311: 89–93.
Mathiesen ER, Oxenbøll B, Johansen K, Svendsen PA, Deckert T. Incipient nephropathy in type 1 (insulin-dependent) diabetes. Diabetologia 1984; 26: 406–410.
Feldt-Rasmussen B, Mathiesen ER, Jensen T, Lauritzen T, Deckert T. Effect of improved metabolic control on loss of kidney function in type I (insulin-dependent) diabetic patients: an update of the Steno studies. Diabetologia 1991; 34: 164–170.
Reichard P, Berglund B, Britz A, Cars I, Nilsson BY, Rosenquist U. Intensified conventional insulin treatment retards the microvascular complications of insulin dependent diabetes mellitus (IDDM): The Stockholm diabetes intervention study (SDIS) after five years. J Intern Med 1991; 230: 101–108.
Dahl-Jørgensen K, Bjøro T, Kierulf P, Sandvik L, Bangstad H-J, Hanssen KF. Long-term glycemic control and kidney function in insulin-dependent diabetes mellitus. Kidney Int 1992; 41: 920–923.
Østerby R. Morphometric studies of the peripheral glomerular basement membrane in early juvenile diabetes. I. Development of initial basement membrane thickening. Diabetologia 1972; 8: 84–92.
Østerby R. A quantitative electron microscopic study of mesangial regions in glomeruli from patients with short term juvenile diabetes mellitus. Lab Invest 1973; 29: 99–110.
Gundersen HJG, Bendtsen TF, Korbo L, et al. Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. APMIS 1988; 96: 379–394.
Walker JD, Close CF, Jones SL, et al. Glomerular structure in type I (insulin-dependent) diabetic patients with normo- and microalbuminuria. Kidney Int 1992; 41: 741–748.
Bangstad H-J, Østerby R, Dahl-Jørgensen K, et al. Early glomerulopathy is present in young Type 1 (insulin-dependent) diabetic patients with microalbuminuria. Diabetologia 1993; 36: 523–529.
Østerby R. Early phases in the development of diabetic nephropathy. Acta Med Scand 1975; 574: suppl.: 1–80.
Steffes MW, Sutherland DER, Goetz FC, Rich SS, Mauer SM. Studies of kidney and muscle biopsies in identical twins discordant for type 1 diabetes mellitus. N Engl J Med 1985; 312: 1281–1287.
Chavers BM, Bilous RW, Ellis EN, Steffes MW, Mauer SM. Glomerular lesions and urinary albumin excretion in Type 1 diabetes without overt proteinuria. N Engl J Med 1989; 320: 966–970.
Rasch R. Prevention of diabetic glomerulopathy in streptozotocin diabetic rats by insulin treatment. Glomerular basement membrane thickness. Diabetologia 1979; 16: 319–324.
Rasch R. Prevention of diabetic glomerulopathy in streptozotocin diabetic rats by insulin treatment. The mesangial region. Diabetologia 1979; 17: 243–248.
Kern TS, Engerman RL. Kidney morphology in experimental hyperglycemia. Diabetes 1987; 36: 244–249.
Petersen J, Ross J, Rabkin R. Effect of insulin therapy on established diabetic nephropathy in rats. Diabetes 1988; 37: 1346–1350.
Mauer SM, Brown DM, Matas AJ, Steffes MW. Effects of pancreatic islet transplantation on the increased urinary albumin excretion rates in intact and uninephrectomized rats with diabetes mellitus. Diabetes 1978; 27: 959–964.
Steffes MW, Brown DM, Basgen JM, Mauer SM. Amelioration of mesangial volume and surface alterations following islet transplantation in diabetic rats. Diabetes 1980; 29: 509–515.
Orloff MJ, Yamanaka N, Greenleaf GE, Huang Y, Huang D, Leng X. Reversal of mesangial enlargement in rats with long-standing diabetes by whole pancreas transplantation. Diabetes 1986; 35: 347–354.
Bilous RW, Mauer SM, Sutherland DER, Najarian JS, Goetz FC, Steffes MW. The effect of pancreas transplantation on the glomerular structure of renal allografts in patients with insulin-dependent diabetes. N Engl J Med 1989; 321: 80–85.
Bangstad H-J, Østerby R, Dahl-Jørgensen K, Berg KJ, Hartmann A, Hanssen KF. Improvement of blood glucose control retards the progression of morphological changes in early diabetic nephropathy. Diabetologia 1994; in press.
Barbosa J, Steffes MW, Connett J, Mauer M. Hyperglycemia is causally related to diabetic renal lesions. Diabetes 1992; 41: 9A.
Mogensen CE, Hansen KW. Blood pressure elevation versus abnormal albuminuria in the genesis and prediction of renal disease in diabetes. Diabetes Care 1992; 15: 1192–1204.
Bangstad H-J, Kofoed-Enevoldsen A, Dahl-Jørgensen K, Hanssen KF. Glomerular charge selectivity and the influence of improved blood glucose control in Type 1 diabetic patients with microalbuminuria. Diabetologia 1992; 35: 1165–1170.
Silbiger S, Crowley S, Shan Z, Brownlee M, Satriano J, Schlondorff D. Nonenzymatic glycation of mesangial matrix and prolonged exposure of mesangial matrix to elevated glucose reduces collagen synthesis and proteoglycan charge. Kidney Int 1993; 43: 853–864.
Brownlee M, Spiro RG. Glomerular basement membrane metabolism in the diabetic rat: in vivo studies. Diabetes 1979; 28: 121–125.
Cagliero E, Roth T, Roy S, Lorenzi M. Characteristics and mechanisms of high-glucose-induced overexpression of basement membrane components in cultured human endothelial cells. Diabetes 1991; 40: 102–110.
Roy S, Sala R, Cagliero E, Lorenzi M. Overexpression of fibronectin induced by diabetes or high glucose: phenomenon with a memory. Proc Natl Acad Sci USA 1990; 87: 404–408.
Ledbetter S, Copeland El, Noonan D, Vogeli G, Hassel JR. Altered steady-state mRNA levels of basement membrane proteins in diabetic mouse kidneys and thromboxane synthase inhibition. Diabetes 1990; 39: 196–203.
Poulsom R, Kurkinen M, Prockop DJ, Boot-Handford RP. Increased steady-state levels of laminin B1 mRNA in kidneys of long term streptozotocin-diabetic rats. J Biol Chem 1988; 263: 10072–10076.
Ayo SH, Radnik RA, Garoni JA, Glass II WF, Kreisberg JI. High glucose causes an increase in extracellular matrix proteins in cultured mesangial cells. Am J Pathol 1990; 136: 1339–1348.
Shimomura H, Spiro RG. Studies on the macromolecular components of human glomerular basement membrane and alterations in diabetes: decreased levels of heparan sulfate proteoglycan and laminin. Diabetes 1987; 36: 374–381.
Olgemøller B, Schwabbe S, Gerbitz KD, Schleicher ED. Elevated glucose decreases the content of a basement associated heparan sulphate proteoglycan in proliferating cultured porcine mesangial cells. Diabetologia 1992; 35: 183–186.
Brownlee M, Vlassara H, Cerami A. Nonenzymatic glycosylation and the pathogenesis of diabetic complications. Ann Intern Med 1984; 101: 527–537.
Østerby R, Nyberg G. New vessel formation in the renal corpuscles in advanced diabetic glomerulopathy. J Diabetic Complications 1987; 1: 122–127.
Østerby R. Renal pathology in diabetes mellitus. Curr Opin Nephrol Hypertens 1993; 2: 475–483.
Kashgarian M, Sterzel RB. The pathobiology of the mesangium. Kidney Int 1992; 41: 524–529.
Hawkins NJ, Wakefield D, Charlesworth JA. The role of mesangial cells in glomerular pathology. Pathology 1990; 22: 24–32.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer Science+Business Media New York
About this chapter
Cite this chapter
Bangstad, HJ., Østerby, R. (1994). Glomerular Ultrastructural Changes in Microalbuminuric IDDM-Patients. In: Mogensen, C.E. (eds) The Kidney and Hypertension in Diabetes Mellitus. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-6746-9_16
Download citation
DOI: https://doi.org/10.1007/978-1-4757-6746-9_16
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-6748-3
Online ISBN: 978-1-4757-6746-9
eBook Packages: Springer Book Archive